Literature DB >> 16448998

Pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. Ten years experience in Denmark.

Søren Mellemkjaer1, Lars B Ilkjaer, Kaj E Klaaborg, Christian L Christiansen, Inge K Severinsen, Jens E Nielsen-Kudsk, Henrik Allermand, Marianne Egeblad, Bent O Kristensen.   

Abstract

OBJECTIVES: To evaluate survival and functional outcome in patients treated by pulmonary endarterectomy (PEA) for chronic thromboembolic pulmonary hypertension in Denmark.
DESIGN: Follow-up of the first 50 patients operated at Aarhus University Hospital, Denmark.
RESULTS: Fifty patients underwent PEA in the period from 1994 to mid 2004. Prior to surgery all patients were in World Health Organization (WHO) function class III (n=33) or IV (n=17). The mean pulmonary artery pressure was 50 mmHg (range 25-76), cardiac index 1.8 l min(-1)m(-2) (range 0.8-2.8) and pulmonary vascular resistance 819 dyn s cm(-5) (range 241-3,067). In-hospital mortality was 12/50 (24%). Surgical mortality was highest in the early period. Since year 2000 in-hospital deaths occurred in only 2 among 23 patients (9%). Leading causes of death were persistent pulmonary hypertension and bleeding. Three patients died during long-term follow-up with a median observation time of 3 years. The overall 5 year survival rate was 74%. At 3 months follow-up 90% of the patients (34/38) had improved one or more WHO functional classes and the systolic pulmonary artery pressure estimated by Doppler echocardiography had decreased from 80 mmHg (range 49-115) to 43 mmHg (range 14-95).
CONCLUSION: Pulmonary endarterectomy has been successfully implemented in Denmark. The perioperative mortality was reduced over time to 9% during the past 5 years. Functional outcome and long-term survival were excellent stressing the importance of surgical treatment for chronic thromboembolic pulmonary hypertension.

Entities:  

Mesh:

Year:  2006        PMID: 16448998     DOI: 10.1080/14017430500338513

Source DB:  PubMed          Journal:  Scand Cardiovasc J        ISSN: 1401-7431            Impact factor:   1.589


  9 in total

1.  Dynamic Risk Stratification of Patient Long-Term Outcome After Pulmonary Endarterectomy: Results From the United Kingdom National Cohort.

Authors:  John E Cannon; Li Su; David G Kiely; Kathleen Page; Mark Toshner; Emilia Swietlik; Carmen Treacy; Anie Ponnaberanam; Robin Condliffe; Karen Sheares; Dolores Taboada; John Dunning; Steven Tsui; Choo Ng; Deepa Gopalan; Nicholas Screaton; Charlie Elliot; Simon Gibbs; Luke Howard; Paul Corris; James Lordan; Martin Johnson; Andrew Peacock; Robert MacKenzie-Ross; Benji Schreiber; Gerry Coghlan; Kostas Dimopoulos; Stephen J Wort; Sean Gaine; Shahin Moledina; David P Jenkins; Joanna Pepke-Zaba
Journal:  Circulation       Date:  2016-04-06       Impact factor: 29.690

2.  Thromboendarterectomy as treatment in the antiphospholipid syndrome.

Authors:  Suzette W Peng; Jeanne P Mitchell
Journal:  MedGenMed       Date:  2006-07-11

3.  Diagnostic evaluation and management of chronic thromboembolic pulmonary hypertension: a clinical practice guideline.

Authors:  Sanjay Mehta; Doug Helmersen; Steeve Provencher; Naushad Hirani; Fraser D Rubens; Marc De Perrot; Mark Blostein; Kim Boutet; George Chandy; Carole Dennie; John Granton; Paul Hernandez; Andrew M Hirsch; Karen Laframboise; Robert D Levy; Dale Lien; Simon Martel; Gerard Shoemaker; John Swiston; Justin Weinkauf
Journal:  Can Respir J       Date:  2010 Nov-Dec       Impact factor: 2.409

4.  Association of residual pulmonary hypertension with survival after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension.

Authors:  Janica Kallonen; Kasper Korsholm; Fredrik Bredin; Matthias Corbascio; Mads Jønsson Andersen; Lars Bo Ilkjær; Søren Mellemkjær; Ulrik Sartipy
Journal:  Pulm Circ       Date:  2022-05-27       Impact factor: 2.886

5.  Pulmonary endarterectomy after pulmonary infectious embolisms.

Authors:  Johan Heiberg; Lars B Ilkjær
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-12-17

Review 6.  Respiratory and hemodynamic changes in patients with chronic thromboembolic pulmonary hypertension 1 year after pulmonary endarterectomy.

Authors:  Masato Sato; Motomi Ando; Kan Kaneko; Yoshiro Higuchi; Hiroshi Kondo; Kiyotoshi Akita; Michiko Ishida; Yasushi Takagi
Journal:  Ann Vasc Dis       Date:  2013-08-12

7.  Pulmonary thromboendarterectomy after treatment with treprostenil in a chronic thromboembolic pulmonary hypertension patient: a case report.

Authors:  Konstantinos Porpodis; Maria Konoglou; Paul Zarogoulidis; Evangelos Kaimakamis; Theodoros Kontakiotis; Despoina Papakosta; Vasilis Zervas; Nikolaos Katsikogiannis; Nikolaos Courcoutsakis; Alexandros Mitrakas; Panagiotis Touzopoulos; Michael Karanikas; Konstantinos Zarogoulidis; Aikaterini Markopoulou
Journal:  Int J Gen Med       Date:  2011-11-08

8.  Sex and survival following pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: a Scandinavian observational cohort study.

Authors:  Janica Kallonen; Kasper Korsholm; Fredrik Bredin; Matthias Corbascio; Mads Jønsson Andersen; Lars Bo Ilkjær; Søren Mellemkjær; Ulrik Sartipy
Journal:  Pulm Circ       Date:  2021-10-27       Impact factor: 3.017

9.  An Australian tertiary referral center experience of the management of chronic thromboembolic pulmonary hypertension.

Authors:  Videshinie A Maliyasena; Peter M A Hopkins; Bruce M Thomson; John Dunning; Douglas A Wall; Benjamin J Ng; Keith D McNeil; Daniel Mullany; Fiona D Kermeen
Journal:  Pulm Circ       Date:  2012-07       Impact factor: 3.017

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.